Search
Close this search box.
Logo Asphalion

NEWS | FDA Guidance on Rare Disease Drug Development

January 11, 2024

The FDA has published a new guidance on drug development for rare diseases, “Rare Diseases: Considerations for the Development of Drugs and Biological Products Guidance for Industry”. This guide allows and encourages pharmaceutical innovation by offering a framework for tackling the unique complexity of rare disease therapy creation.

Key takeaways from the FDA’s guide:

  • Personalized Disease Understanding: The importance of grasping the progression of rare diseases to inform drug discovery and patient care.
  • Nonclinical considerations to adapt programmes to the specific difficulty of research with rare diseases.
  • Cutting-Edge Clinical Strategies: The encouragement of adaptive and flexible trial designs to make the most of small patient groups.
  • Predictive Biomarkers: The use of biomarkers as early indicators of treatment success, a boon for trials with few participants.
  • Streamlined Regulatory Support: Highlighting programmes that expedite the journey from lab to patient for treatments addressing severe or life-threatening rare conditions.

 

The guide for rare disease drug development also highlights the importance of collaboration and planning when handling rare diseases. The community involvement is key, as well as the value of insights from patients, families and advocates when shaping drug development. Moreover, the constant and proactive conversations with the FDA are highly recommended to refine study design and regulatory approaches.

This document marks a transformative approach in drug development, putting patients at the forefront and promoting pharmaceutical innovation.

Read here the whole guide: FDA GUIDANCE ON RARE DISEASE DRUG DEVELOPMENT

Search News & Events

  • Filter by category

Share

Related news and events

NABIHEAL project | 18-month progress meeting

ASPHALION is proud member of the NABIHEAL EU-funded project consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting